Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 8:00 pm Purchase | 2024-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Redmile Group LLC | 13,163,457 8.200% | 3,028,069 (+29.88%) | Filing History |
| 2024-11-07 5:06 pm Sale | 2024-10-31 | 13G | GRITSTONE BIO INC GRTSQ | MORGAN STANLEY MS | 11,387 0.000% | -10,284,278 (-99.89%) | Filing History |
| 2024-11-06 5:34 pm Purchase | 2024-09-30 | 13G | GRITSTONE BIO INC GRTSQ | MORGAN STANLEY MS | 10,295,665 8.700% | 4,776,563 (+86.55%) | Filing History |
| 2024-10-07 5:01 pm Purchase | 2024-09-30 | 13G | GRITSTONE BIO INC GRTSQ | RedCo II Master Fund L.P. | 8,197,331 6.200% | 8,197,331 (New Position) | Filing History |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | GRITSTONE BIO INC GRTSQ | BlackRock Inc. BLK | 871,995 0.800% | -4,996,358 (-85.14%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Redmile Group LLC | 10,135,388 9.900% | 1,652,066 (+19.47%) | Filing History |
| 2024-02-14 10:06 am Sale | 2023-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Point72 Asset Management, L.P. | 3,974,873 4.200% | -3,727,958 (-48.40%) | Filing History |
| 2024-02-13 12:44 pm Sale | 2023-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Frazier Life Sciences Public Fund, L.P. | 1,092,185 1.100% | -4,131,470 (-79.09%) | Filing History |
| 2024-02-08 10:59 am Purchase | 2023-12-31 | 13G | GRITSTONE BIO INC GRTSQ | MORGAN STANLEY MS | 5,519,102 5.800% | 5,519,102 (New Position) | Filing History |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | GRITSTONE BIO INC GRTSQ | BlackRock Inc. BLK | 5,868,353 6.200% | 3,954,482 (+206.62%) | Filing History |
| 2023-02-14 4:23 pm Purchase | 2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Point72 Asset Management, L.P. | 7,702,831 9.200% | 1,094,273 (+16.56%) | Filing History |
| 2023-02-14 4:20 pm Purchase | 2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Redmile Group LLC | 8,483,322 9.900% | 1,217,808 (+16.76%) | Filing History |
| 2023-02-14 3:23 pm Sale | 2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Avidity Partners Management LP | 2,859,971 3.300% | -4,130,223 (-59.09%) | Filing History |
| 2023-02-14 12:08 pm Purchase | 2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Frazier Life Sciences Public Fund, L.P. | 5,223,655 6.300% | 495,104 (+10.47%) | Filing History |
| 2023-02-10 1:48 pm Sale | 2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ | EcoR1 Capital LLC | 0 0.000% | -6,319,232 (Position Closed) | Filing History |
| 2023-02-09 4:30 pm Unchanged | 2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Versant Venture Capital V L.P. | 2,895,695 3.500% | 0 (Unchanged) | Filing History |
| 2023-02-03 2:34 pm Sale | 2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ | STATE STREET CORP STT | 280,330 0.340% | -3,393,449 (-92.37%) | Filing History |
| 2022-10-31 8:22 pm Purchase | 2022-10-28 | 13G | GRITSTONE BIO INC GRTSQ | Point72 Asset Management, L.P. | 6,608,558 8.000% | 6,608,558 (New Position) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | GRITSTONE BIO INC GRTSQ | BlackRock Inc. BLK | 1,913,871 2.600% | -1,877,562 (-49.52%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Redmile Group LLC | 7,265,514 9.900% | 1,535,598 (+26.80%) | Filing History |